No excess risk of adverse pregnancy outcomes among women with serological markers of previous infection with Coxiella burnetii: Evidence from the Danish National Birth Cohort

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Nielsen, Stine Yde ^a,b   Andersen, Anne Marie Nybo ^c   Mølbak, Kåre ^d   Hjøllund, Niels Henrik ^a,b   Kantsø, Bjørn ^d   Krogfelt, Karen Angeliki ^d   Henriksen, Tine Brink ^b  

^a REGIONAL HOSPITAL WEST JUTLAND   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

Coxiella burnetii; Human; Infection; Pregnancy; Preterm birth; Q fever; Spontaneous abortion

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ADVERSE OUTCOME; ANTIBODY SCREENING; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; COHORT ANALYSIS; COXIELLA BURNETII; DISEASE ASSOCIATION; DISEASE MARKER; DOMESTIC ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; LIVESTOCK; MAJOR CLINICAL STUDY; OCCUPATIONAL EXPOSURE; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; Q FEVER; RISK ASSESSMENT; SEROCONVERSION; SEROLOGY; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; WOMEN'S HEALTH;

ADULT; ANTIBODIES, BACTERIAL; BIRTH WEIGHT; COXIELLA BURNETII; DENMARK; FEMALE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; Q FEVER; YOUNG ADULT;

EID: 84873717952     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-87     Document Type: Article

References (25)

1. Berri M, Rousset E, Champion JL, Russo P, Rodolakis A. Goats may experience reproductive failures and shed coxiella burnetii at two successive parturitions after a Q fever infection. Res Vet Sci 2007, 83(1):47-52. 10.1016/j.rvsc.2006.11.001, 17187835.
2. Bildfell RJ, Thomson GW, Haines DM, McEwen BJ, Smart N. Coxiella burnetii infection is associated with placentitis in cases of bovine abortion. J Vet Diagn Invest 2000, 12(5):419-425. 10.1177/104063870001200505, 11021428.
3. Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J Clin Microbiol 1998, 36(7):1823-1834. 104936, 9650920.
4. Parker NR, Barralet JH, Bell AM. Q fever. Lancet 2006, 367(9511):679-688. 10.1016/S0140-6736(06)68266-4, 16503466.
5. Tissot-Dupont H, Vaillant V, Rey S, Raoult D. Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis 2007, 44(2):232-237. 10.1086/510389, 17173223.
6. Agger JF, Christoffersen AB, Rattenborg E, Nielsen J, Agerholm JS. Prevalence of coxiella burnetii antibodies in Danish dairy herds. Acta Vet Scand 2010, 52:5. 10.1186/1751-0147-52-5, 2823749, 20092653.
7. Bacci S, Villumsen S, Valentiner-Branth P, Smith B, Krogfelt KA, Molbak K. Epidemiology and clinical features of human infection with coxiella burnetii in Denmark during 2006-07. Zoonoses Public Health 2011, 59(1):61-68.
8. Bosnjak E, Hvass AM, Villumsen S, Nielsen H. Emerging evidence for Q fever in humans in Denmark: role of contact with dairy cattle. Clin Microbiol Infect 2010, 16(8):1285-1288.
9. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis 2007, 45(5):548-555. 10.1086/520661, 17682987.
10. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Q fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci 2009, 1166:79-89. 10.1111/j.1749-6632.2009.04519.x, 19538266.
11. Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med 2002, 162(6):701-704. 10.1001/archinte.162.6.701, 11911725.
12. Munster JM. Effectivenss of a screening program for Q fever during pregnancy: a clustered randomised controlled trial 2011, Stockholm: Presentantion at the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE), abstract.
13. van der Hoek W, Meekelenkamp JC, Leenders AC, Wijers N, Notermans DW, Hukkelhoven CW. Antibodies against coxiella burnetii and pregnancy outcome during the 2007-2008 Q fever outbreaks in the Netherlands. BMC Infect Dis 2011, 11:44. 10.1186/1471-2334-11-44, 3042933, 21314933.
14. Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM, Taxbol D, Hansen KD, Juhl M, Schow TB, Sorensen HT, Andresen J, Mortensen EL, Olesen AW, Sondergaard C. The danish national birth cohort-its background, structure and aim. Scand J Public Health 2001, 29(4):300-307.
15. Marmion BP, Storm PA, Ayres JG, Semendric L, Mathews L, Winslow W, Turra M, Harris RJ. Long-term persistence of coxiella burnetii after acute primary Q fever. QJM 2005, 98(1):7-20. 10.1093/qjmed/hci009, 15625349.
16. Villumsen S, Jorgensen CS, Smith B, Uldum S, Schiellerup P, Krogfelt KA. Determination of new cutoff values for indirect immunofluorescence antibody test for Q fever diagnosis in Denmark. Diagn Microbiol Infect Dis 2009, 65(2):93-98. 10.1016/j.diagmicrobio.2009.06.004, 19748417.
17. Field PR, Mitchell JL, Santiago A, Dickeson DJ, Chan SW, Ho DW, Murphy AM, Cuzzubbo AJ, Devine PL. Comparison of a commercial enzyme-linked immunosorbent assay with immunofluorescence and complement fixation tests for detection of coxiella burnetii (Q fever) immunoglobulin M. J Clin Microbiol 2000, 38(4):1645-1647. 86512, 10747159.
18. Kantso B, Svendsen CB, Jorgensen CS, Krogfelt KA. Comparison of two commercially available ELISA antibody test kits for detection of human antibodies against coxiella burnetii. Scand J Infect Dis 2012, 44(7):489-494. 10.3109/00365548.2012.664777, 22385345.
19. Field PR, Santiago A, Chan SW, Patel DB, Dickeson D, Mitchell JL, Devine PL, Murphy AM. Evaluation of a novel commercial enzyme-linked immunosorbent assay detecting coxiella burnetii-specific immunoglobulin G for Q fever prevaccination screening and diagnosis. J Clin Microbiol 2002, 40(9):3526-3529. 10.1128/JCM.40.9.3526-3529.2002, 130813, 12202611.
20. Angelakis E, Raoult D. Q fever. Vet Microbiol 2010, 140(3-4):297-309.
21. Nielsen SY, Hjollund NH, Andersen AM, Henriksen TB, Kantso B, Krogfelt KA, Molbak K. Presence of antibodies against coxiella burnetii and risk of spontaneous abortion: a nested case-control study. PLoS One 2012, 7(2):e31909. 10.1371/journal.pone.0031909, 3283715, 22363769.
22. Whitney EA, Massung RF, Candee AJ, Ailes EC, Myers LM, Patterson NE, Berkelman RL. Seroepidemiologic and occupational risk survey for coxiella burnetii antibodies among US veterinarians. Clin Infect Dis 2009, 48(5):550-557. 10.1086/596705, 19191638.
23. Angelakis E, Million M, D'Amato F, Rouli L, Richet H, Stein A, Rolain JM, Raoult D. Q fever and pregnancy: disease, prevention, and strain specificity. Eur J Clin Microbiol Infect Dis 2012, 32(3):361-368.
24. Boden K, Brueckmann A, Wagner-Wiening C, Hermann B, Henning K, Junghanss T, Seidel T, Baier M, Straube E, Theegarten D. Maternofetal consequences of coxiella burnetii infection in pregnancy: a case series of two outbreaks. BMC Infect Dis 2012, 12(1):359. 10.1186/1471-2334-12-359, 3541954, 23249469.
25. van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vellema P, Wijkmans C, ter Schegget R, Hackert V, van Duynhoven Y. Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill 2010, 15(12):19520.